We actually take comfort in the fact that BIOF management refrains from putting out a bunch of fluff press releases.
So many other OTC companies and penny stocks do this, hoping to somehow "manage the stock price".
These guys are managing the company, knowing that the stock price will eventually reflect the value of the CTS 2.0 technology.
They know what they have, and what it is worth.
Once the market figures this out, and they release information for the world to see, this stock should attract a lot of new investors bidding against each other for position.
In the meantime, we wait patiently for that day to come.